Catherine K. Floroff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Catherine K. Floroff has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Gretchen M. Brophy
Virginia Commonwealth University
2 shared publications - Patricia W. Slattum
Virginia Commonwealth Univ, Sch Pharm, Dept Pharmacotherapy & Outcomes Sci, Geriatr Pharmacotherapy Program, Richmond, VA 23298 USA
2 shared publications - Perry Taylor
Virginia Commonwealth University
2 shared publications - Spencer E. Harpe
Department of Pharmacy Practice, College of Pharmacy, Midwestern University , 555 31st Street, Downers Grove, IL 60515
2 shared publications
Latest Publications
- 13 September 2014
- Published by Springer Nature in Neurocritical Care
- Vol. 21 (2) , 367-368
Response to “Modifications to the Drug Burden Index Calculation May Limit Interpretation of Its Association With Clinical Outcomes In Older Adults”(doi:10.1007/s12028-014-0006-8)
- 13 September 2014
- Published by Springer Nature in Neurocritical Care
- Vol. 21 (2) , 367-368
Response to “Modifications to the Drug Burden Index Calculation May Limit Interpretation of Its Association With Clinical Outcomes In Older Adults”(doi:10.1007/s12028-014-0006-8)
- 8 May 2014
- Published by Springer Nature in Neurocritical Care
- Vol. 21 (3) , 526-533
Potentially Inappropriate Medication Use is Associated with Clinical Outcomes in Critically Ill Elderly Patients with Neurological Injury
Limited data suggest that potentially inappropriate medications (PIMs) impact outcomes in critically ill elderly patients. No data are available on the association between PIM use as well as drug burden index (DBI), which is a measure of PIM use, and clinical outcomes in neurocritical care elderly patients. This study evaluates whether PIM use and a higher DBI are associated with poor clinical outcomes in neurocritical care elderly patients. PIMs were retrospectively identified in critically ill elderly patients admitted to the neuroscience intensive care unit (NSICU) from March to July 2011. DBI was calculated based on PIM doses. Relationships with clinical outcomes were evaluated. PIMs were prescribed to a majority (81.3 %) of the 112 patients. Opioids were most commonly associated with a decrease in Richmond Agitation Sedation Scale (RASS) scores (56 % of PIM doses). Time to recovery was significantly longer in patients with a higher PIM burden (≤2 PIMs: 8 h, >2 PIMs: 29 h; p = 0.02). There was a significantly longer NSICU and hospital length of stay (9 vs 2; 15 vs 5 days; p < 0.0001) as well as a lower Glasgow Coma Scale score upon discharge (14 vs 15, p = 0.02) in patients with a higher DBI after 72 h of hospitalization. There was no difference in mortality. PIM use and higher DBI scores were associated with poor clinical outcomes and longer lengths of stay. Further studies are needed to determine the impact of PIMs and DBI on mortality in neurocritical care elderly patients.
- 8 May 2014
- Published by Springer Nature in Neurocritical Care
- Vol. 21 (3) , 526-533
Potentially Inappropriate Medication Use is Associated with Clinical Outcomes in Critically Ill Elderly Patients with Neurological Injury
Limited data suggest that potentially inappropriate medications (PIMs) impact outcomes in critically ill elderly patients. No data are available on the association between PIM use as well as drug burden index (DBI), which is a measure of PIM use, and clinical outcomes in neurocritical care elderly patients. This study evaluates whether PIM use and a higher DBI are associated with poor clinical outcomes in neurocritical care elderly patients. PIMs were retrospectively identified in critically ill elderly patients admitted to the neuroscience intensive care unit (NSICU) from March to July 2011. DBI was calculated based on PIM doses. Relationships with clinical outcomes were evaluated. PIMs were prescribed to a majority (81.3 %) of the 112 patients. Opioids were most commonly associated with a decrease in Richmond Agitation Sedation Scale (RASS) scores (56 % of PIM doses). Time to recovery was significantly longer in patients with a higher PIM burden (≤2 PIMs: 8 h, >2 PIMs: 29 h; p = 0.02). There was a significantly longer NSICU and hospital length of stay (9 vs 2; 15 vs 5 days; p < 0.0001) as well as a lower Glasgow Coma Scale score upon discharge (14 vs 15, p = 0.02) in patients with a higher DBI after 72 h of hospitalization. There was no difference in mortality. PIM use and higher DBI scores were associated with poor clinical outcomes and longer lengths of stay. Further studies are needed to determine the impact of PIMs and DBI on mortality in neurocritical care elderly patients.